UBC Medical Indonesia Tbk. vs Rohartindo Nusantara Luas Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Rohartindo Nusantara Luas Tbk. trades at Rp69 (market cap 141.45B, 20.96M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 4.1× Rohartindo Nusantara Luas Tbk.'s market cap, and Rohartindo Nusantara Luas Tbk. is more actively traded (20.96M versus 3.48M). Which is the better fit depends on your goals.
| LABS | TOOL | |
|---|---|---|
Market Cap | 576.7B | 141.45B |
Volume | 3.48M | 20.96M |
Lot | 34.82K | 209.65K |
Turnover | 522.79M | 1.44B |
Average Price | 150.13 | 68.75 |
Value | 522.79M | 1.44B |
Indicative Equilibrium Price | 148 | 69 |
Indicative Equilibrium Volume | 350 | 9.21K |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT Rohartindo Nusantara Luas Tbk ("The Company") was established based on Notarial Deed of Sudiono Abady, S.H., No. 2 dated October 4, 2014. The Company started its commercial operations in June 2015.
Read more on TOOL →